Results 181 to 190 of about 1,990 (201)

Thinking outside the box: non-canonical targets in multiple sclerosis

Nature Reviews Drug Discovery, 2022
Laura Bierhansl, Orhan Aktas, Tobias Ruck   +2 more
exaly  

Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod

Multiple Sclerosis Journal, 2012
H-P Hartung
exaly  

Efficacy of tocilizumab for fulminant multiple sclerosis with a tumefactive cervical lesion: A 12-year-old boy

Multiple Sclerosis and Related Disorders, 2020
Hiroki Hoshino, Takashi Yamamura, Yoko Shirai   +2 more
exaly  

Remyelination therapies: a new direction and challenge in multiple sclerosis

Nature Reviews Drug Discovery, 2017
Jason R Plemel, Voon Wee Yong
exaly  

Is size an essential criterion to define tumefactive plaque? MR features and clinical correlation in multiple sclerosis

Neuroradiology Journal, 2016
Rocco Totaro, Ernesto Di Cesare, Alessandra Splendiani   +2 more
exaly  

Tumefactive Demyelination in Multiple Sclerosis

2018
Meredith C. Frederick, Michelle H. Cameron   +1 more
openaire   +1 more source

Usefulness of [¹¹C] Methionine PET in the Differentiation of Tumefactive Multiple Sclerosis from High Grade Astrocytoma

Neurologia Medico-Chirurgica, 2019
Motoki Inaji, Tadashi Nariai, Daisuke Kobayashi   +2 more
exaly  

Case 33: Tumefactive Multiple Sclerosis Lesions (TMS)

2021
Silvia Morbelli, Stefano Raffa
openaire   +1 more source

Progressive multiple sclerosis: from pathophysiology to therapeutic strategies

Nature Reviews Drug Discovery, 2019
Simon Faissner, Jason R Plemel, Ralf Gold   +2 more
exaly  

Immunopathology of multiple sclerosis

Nature Reviews Immunology, 2015
Calliope A Dendrou, Lars Fugger, Manuel A. Friese   +2 more
exaly